Driving regeneration, instead of healing, in adult mammals: the decisive role of resident macrophages through efferocytosis.


Journal

NPJ Regenerative medicine
ISSN: 2057-3995
Titre abrégé: NPJ Regen Med
Pays: United States
ID NLM: 101699846

Informations de publication

Date de publication:
03 Aug 2021
Historique:
received: 04 08 2020
accepted: 07 07 2021
entrez: 4 8 2021
pubmed: 5 8 2021
medline: 5 8 2021
Statut: epublish

Résumé

Tissue repair after lesion usually leads to scar healing and thus loss of function in adult mammals. In contrast, other adult vertebrates such as amphibians have the ability to regenerate and restore tissue homeostasis after lesion. Understanding the control of the repair outcome is thus a concerning challenge for regenerative medicine. We recently developed a model of induced tissue regeneration in adult mice allowing the comparison of the early steps of regenerative and scar healing processes. By using studies of gain and loss of function, specific cell depletion approaches, and hematopoietic chimeras we demonstrate here that tissue regeneration in adult mammals depends on an early and transient peak of granulocyte producing reactive oxygen species and an efficient efferocytosis specifically by tissue-resident macrophages. These findings highlight key and early cellular pathways able to drive tissue repair towards regeneration in adult mammals.

Identifiants

pubmed: 34344890
doi: 10.1038/s41536-021-00151-1
pii: 10.1038/s41536-021-00151-1
pmc: PMC8333253
doi:

Types de publication

Journal Article

Langues

eng

Pagination

41

Subventions

Organisme : Fondation pour la Recherche Médicale (Foundation for Medical Research in France)
ID : FDT201904008033
Organisme : Agence Nationale de la Recherche (French National Research Agency)
ID : ANR 16-CE14-0006-01

Informations de copyright

© 2021. The Author(s).

Références

Nature. 2016 Jan 21;529(7586):307-15
pubmed: 26791721
Nat Rev Immunol. 2010 Jun;10(6):427-39
pubmed: 20498669
Immunity. 2019 Jun 18;50(6):1482-1497.e7
pubmed: 31201094
Science. 2017 Jun 9;356(6342):1026-1030
pubmed: 28596335
Elife. 2017 Jun 28;6:
pubmed: 28656887
Mol Ther Oncolytics. 2020 Apr 28;17:394-407
pubmed: 32346605
Cell Metab. 2008 Oct;8(4):301-9
pubmed: 18840360
Nat Rev Immunol. 2008 May;8(5):349-61
pubmed: 18437155
Nature. 2018 Nov;563(7733):714-718
pubmed: 30464343
J Exp Med. 2016 Jun 27;213(7):1353-74
pubmed: 27353089
Trends Endocrinol Metab. 2015 Sep;26(9):449-50
pubmed: 26250053
Cytokine. 1996 Jul;8(7):548-56
pubmed: 8891436
Biochim Biophys Acta. 2013 Jul;1832(7):989-97
pubmed: 23246690
Blood. 2018 May 24;131(21):2367-2378
pubmed: 29618478
Immunity. 2017 Aug 15;47(2):349-362.e5
pubmed: 28801233
J Cell Biol. 2011 Oct 17;195(2):307-22
pubmed: 21987635
Nat Rev Immunol. 2013 Mar;13(3):159-75
pubmed: 23435331
Nature. 2008 May 15;453(7193):314-21
pubmed: 18480812
Sci Rep. 2020 Feb 20;10(1):3095
pubmed: 32080283
Science. 2012 Apr 6;336(6077):86-90
pubmed: 22442384
Development. 2014 Jul;141(13):2581-91
pubmed: 24961798
J Exp Med. 2013 Apr 8;210(4):775-88
pubmed: 23547101
J Leukoc Biol. 2019 Jan;105(1):195-202
pubmed: 30265749
J Clin Invest. 2019 Jun 17;129(7):2629-2639
pubmed: 31205028
Curr Protoc Immunol. 2008 Feb;Chapter 22:Unit 22B.2
pubmed: 18432636
Nat Med. 2009 Apr;15(4):455-61
pubmed: 19305414
Front Immunol. 2018 Feb 06;9:111
pubmed: 29467755
Cell Death Dis. 2017 Aug 10;8(8):e2979
pubmed: 28796253
Front Immunol. 2019 Dec 20;10:2904
pubmed: 31921165
Cytokine. 2015 Jul;74(1):62-8
pubmed: 25649043
Proc Natl Acad Sci U S A. 2014 Nov 11;111(45):16029-34
pubmed: 25349429
Stem Cells. 2010 Nov;28(11):2065-72
pubmed: 20845475
Nat Rev Immunol. 2011 Oct 14;11(11):723-37
pubmed: 21997792
Diabetes. 2008 Dec;57(12):3239-46
pubmed: 18829989
J Clin Invest. 2014 Mar;124(3):1382-92
pubmed: 24569380
Circ Res. 2016 May 13;118(10):1498-511
pubmed: 27009605
Annu Rev Immunol. 2018 Apr 26;36:489-517
pubmed: 29400998
FASEB J. 2019 Aug;33(8):8809-8821
pubmed: 31042406
J Comp Neurol. 2007 Jan 10;500(2):267-85
pubmed: 17111361
Proc Natl Acad Sci U S A. 2012 Nov 13;109(46):E3186-95
pubmed: 23100531
Mol Cell Biol. 2014 Apr;34(8):1512-20
pubmed: 24515440
Sci Rep. 2018 Aug 15;8(1):12170
pubmed: 30111876
Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):9415-20
pubmed: 23690624
Immunol Cell Biol. 2019 Mar;97(3):279-288
pubmed: 30680784
Nature. 2012 Sep 27;489(7417):561-5
pubmed: 23018966
Nat Commun. 2019 Mar 6;10(1):1076
pubmed: 30842418
J Clin Invest. 2005 Jan;115(1):56-65
pubmed: 15630444
NPJ Regen Med. 2017;2:
pubmed: 29201433
Blood. 2012 Dec 13;120(25):4952-62
pubmed: 23071275
Nutr Metab Cardiovasc Dis. 2016 Mar;26(3):246-53
pubmed: 26841679
Antioxid Redox Signal. 2014 Mar 1;20(7):1126-67
pubmed: 23991888
J Leukoc Biol. 2017 Sep;102(3):845-855
pubmed: 28642277
Dev Comp Immunol. 2017 Jan;66:98-110
pubmed: 26891614
Immunity. 2016 Mar 15;44(3):450-462
pubmed: 26982353
Science. 2015 Jun 12;348(6240):aaa2340
pubmed: 26068857
J Exp Med. 2007 May 14;204(5):1057-69
pubmed: 17485518
Antioxidants (Basel). 2018 Nov 06;7(11):
pubmed: 30404180
Elife. 2017 May 16;6:
pubmed: 28508748

Auteurs

Lise Rabiller (L)

STROMALab, Université de Toulouse, CNRS ERL5311, EFS, ENVT, Inserm U1031, UPS, Toulouse, France.
Department of Physiology and Cell Information Systems, McGill University, Montreal; Alan Edwards Center for Research on Pain, McGill University, Montreal, QC, Canada.

Virginie Robert (V)

STROMALab, Université de Toulouse, CNRS ERL5311, EFS, ENVT, Inserm U1031, UPS, Toulouse, France.

Adèle Arlat (A)

STROMALab, Université de Toulouse, CNRS ERL5311, EFS, ENVT, Inserm U1031, UPS, Toulouse, France.
RESTORE Institute, UMR 1301-Inserm 5070-CNRS EFS Univ. P. Sabatier, Toulouse, France.

Elodie Labit (E)

STROMALab, Université de Toulouse, CNRS ERL5311, EFS, ENVT, Inserm U1031, UPS, Toulouse, France.
Department of Comparative Biology and Experimental Medicine, Faculty of Veterinary Medicine, University of Calgary, Calgary, AB, Canada.

Marielle Ousset (M)

STROMALab, Université de Toulouse, CNRS ERL5311, EFS, ENVT, Inserm U1031, UPS, Toulouse, France.
RESTORE Institute, UMR 1301-Inserm 5070-CNRS EFS Univ. P. Sabatier, Toulouse, France.

Marie Salon (M)

UMR 152 Pharma Dev, Université de Toulouse, IRD, UPS, Toulouse, France.
RESTORE Institute, UMR 1301-Inserm 5070-CNRS EFS Univ. P. Sabatier, Toulouse, France.

Agnès Coste (A)

UMR 152 Pharma Dev, Université de Toulouse, IRD, UPS, Toulouse, France.
RESTORE Institute, UMR 1301-Inserm 5070-CNRS EFS Univ. P. Sabatier, Toulouse, France.

Léa Da Costa-Fernandes (L)

STROMALab, Université de Toulouse, CNRS ERL5311, EFS, ENVT, Inserm U1031, UPS, Toulouse, France.
RESTORE Institute, UMR 1301-Inserm 5070-CNRS EFS Univ. P. Sabatier, Toulouse, France.

Paul Monsarrat (P)

STROMALab, Université de Toulouse, CNRS ERL5311, EFS, ENVT, Inserm U1031, UPS, Toulouse, France.
RESTORE Institute, UMR 1301-Inserm 5070-CNRS EFS Univ. P. Sabatier, Toulouse, France.

Bruno Ségui (B)

UMR 1037, Centre de recherche en cancérologie de Toulouse (CRCT), Université de Toulouse, INSERM, UPS, Toulouse, France.

Mireille André (M)

STROMALab, Université de Toulouse, CNRS ERL5311, EFS, ENVT, Inserm U1031, UPS, Toulouse, France.
RESTORE Institute, UMR 1301-Inserm 5070-CNRS EFS Univ. P. Sabatier, Toulouse, France.

Christophe Guissard (C)

STROMALab, Université de Toulouse, CNRS ERL5311, EFS, ENVT, Inserm U1031, UPS, Toulouse, France.
RESTORE Institute, UMR 1301-Inserm 5070-CNRS EFS Univ. P. Sabatier, Toulouse, France.

Marie-Laure Renoud (ML)

STROMALab, Université de Toulouse, CNRS ERL5311, EFS, ENVT, Inserm U1031, UPS, Toulouse, France.
RESTORE Institute, UMR 1301-Inserm 5070-CNRS EFS Univ. P. Sabatier, Toulouse, France.

Marine Silva (M)

Inserm U1213, Université Lyon 1, Villeurbanne, France.

Gilles Mithieux (G)

Inserm U1213, Université Lyon 1, Villeurbanne, France.

Isabelle Raymond-Letron (I)

STROMALab, Université de Toulouse, CNRS ERL5311, EFS, ENVT, Inserm U1031, UPS, Toulouse, France.
RESTORE Institute, UMR 1301-Inserm 5070-CNRS EFS Univ. P. Sabatier, Toulouse, France.

Luc Pénicaud (L)

STROMALab, Université de Toulouse, CNRS ERL5311, EFS, ENVT, Inserm U1031, UPS, Toulouse, France.

Anne Lorsignol (A)

STROMALab, Université de Toulouse, CNRS ERL5311, EFS, ENVT, Inserm U1031, UPS, Toulouse, France.
RESTORE Institute, UMR 1301-Inserm 5070-CNRS EFS Univ. P. Sabatier, Toulouse, France.

Louis Casteilla (L)

STROMALab, Université de Toulouse, CNRS ERL5311, EFS, ENVT, Inserm U1031, UPS, Toulouse, France.
RESTORE Institute, UMR 1301-Inserm 5070-CNRS EFS Univ. P. Sabatier, Toulouse, France.

Cécile Dromard Berthézène (C)

STROMALab, Université de Toulouse, CNRS ERL5311, EFS, ENVT, Inserm U1031, UPS, Toulouse, France.
RESTORE Institute, UMR 1301-Inserm 5070-CNRS EFS Univ. P. Sabatier, Toulouse, France.

Béatrice Cousin (B)

STROMALab, Université de Toulouse, CNRS ERL5311, EFS, ENVT, Inserm U1031, UPS, Toulouse, France. beatrice.cousin@inserm.fr.
RESTORE Institute, UMR 1301-Inserm 5070-CNRS EFS Univ. P. Sabatier, Toulouse, France. beatrice.cousin@inserm.fr.

Classifications MeSH